{"transactions":[{"id":3237406,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-03T00:26:57.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":85000,"derivative":{"exercise_price":8.87,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001562180-20-001934","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001934/primarydocument.xml","form_type":"4"}},{"id":3237405,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-03T00:26:57.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":3454,"price":8.7,"value":30049.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019."}],"balance_after":84679,"source":{"system":"sec-edgar","filing":"0001562180-20-001934","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001934/primarydocument.xml","form_type":"4"}},{"id":3237404,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-03T00:26:57.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,364 shares of the Issuer's common stock purchased on June 28, 2019 and 1,445 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan."}],"balance_after":88133,"source":{"system":"sec-edgar","filing":"0001562180-20-001934","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001934/primarydocument.xml","form_type":"4"}},{"id":3556399,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-04-12T20:00:32.000Z","date":"2019-04-11","kind":"disposition_to_issuer","acquired":false,"shares":6075,"price":7.7,"value":46777.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The proceeds from the disposition of these shares are to be used by the reporting person to cover tax liabilities associated with previously vested restricted stock units."}],"balance_after":55324,"source":{"system":"sec-edgar","filing":"0000899243-19-010588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000089924319010588/doc4.xml","form_type":"4"}},{"id":3610810,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2019-03-05T21:07:36.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":45000,"derivative":{"exercise_price":7.28,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-19-001680","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019001680/primarydocument.xml","form_type":"4"}},{"id":3610809,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:07:36.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended.  One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,170 shares of the Issuer's common stock purchased under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018."}],"balance_after":61399,"source":{"system":"sec-edgar","filing":"0001562180-19-001680","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019001680/primarydocument.xml","form_type":"4"}},{"id":3731826,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-12-13T13:18:51.000Z","date":"2018-12-12","kind":"tax_withholding","acquired":false,"shares":11928,"price":8.94,"value":106636.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 639 shares acquired under the Akebia Therapeutics, Inc. stock purchase plan on June 29, 2018."}],"balance_after":30229,"source":{"system":"sec-edgar","filing":"0000899243-18-030797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000089924318030797/doc4.xml","form_type":"4"}},{"id":4019290,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2018-03-02T21:14:58.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan.  25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":14.3,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-001382","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218018001382/primarydocument.xml","form_type":"4"}},{"id":4019289,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-03-02T21:14:58.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of beneficial securities owned includes 591 shares of stock purchased on June 30, 2017 at $8.92 per share and 427 shares of stock purchased on December 31, 2017 at $12.39 per share in connection with the Issuer's Employee Stock Purchase Plan."}],"balance_after":41518,"source":{"system":"sec-edgar","filing":"0001562180-18-001382","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218018001382/primarydocument.xml","form_type":"4"}},{"id":4427193,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2017-02-23T21:02:45.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":36500,"price":10.14,"value":370110.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":36500,"derivative":{"exercise_price":0,"expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":36500},"source":{"system":"sec-edgar","filing":"0001562180-17-000882","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218017000882/primarydocument.xml","form_type":"4"}},{"id":4427192,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-02-23T21:02:45.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001562180-17-000882","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218017000882/primarydocument.xml","form_type":"4"}},{"id":4534884,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":151169,"kind":"person","name":"Tubridy Karen L","position":1,"cik":"0001589888","reported_name":"Tubridy Karen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2016-12-02T21:05:54.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% of the shares of common stock subject to the award on the first anniversary of the grant date with the\nremaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":8.61,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001562180-16-003658","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218016003658/primarydocument.xml","form_type":"4"}}]}